Study to Evaluate Psoriasis Severity and Its Psychosocial Impact Using the Simplified Psoriasis Index (SPI), as Well as Long-term Safety, Tolerability and Efficacy of Secukinumab Administered Subcutaneously in Patients With Moderate to Severe Psoriasis

Name: Study to Evaluate Psoriasis Severity and Its Psychosocial Impact Using the Simplified Psoriasis Index (SPI), as Well as Long-term Safety, Tolerability and Efficacy of Secukinumab Administered Subcutaneously in Patients With Moderate to Severe Psoriasis
Published: 2015
License: Public Domain

Novartis Pharmaceuticals · 2015

ClinicalTrials.gov · Datasets · License: Public Domain · 2015

Open Source ↗

immune psoriasis

psoriasis, secukinumab, simplified psoriasis index, cain457a, ain457afr01, ain457a, skin condition, skin disease, itching condition, psoriasis vulgaris, relapsing/remitting psoriasis, immune-mediated systemic disease

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 968561
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.